Autophagy and Cancer Dormancy

dc.contributor.author	Akkoc, Y.
dc.contributor.author	Peker, N.
dc.contributor.author	Akcay, A.
dc.contributor.author	Gozuacik, D.
dc.date.accessioned	2021-12-21T08:40:32Z
dc.date.available	2021-12-21T08:40:32Z
dc.date.issued	2021
dc.identifier.uri	https://doi.org/10.3389/fonc.2021.627023
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1049
dc.description.abstract	Metastasis and relapse account for the great majority of cancer-related deaths. Most metastatic lesions are micro metastases that have the capacity to remain in a non-dividing state called “dormancy” for months or even years. Commonly used anticancer drug
dc.description.sponsorship	This work was supported by Scientific and Technological Research Council of Turkey (TUBITAK) grant number 216S489.
dc.title	Autophagy and Cancer Dormancy
dc.relation.journal	Frontiers in Oncology
dc.identifier.volume	11
dc.identifier.doi	10.3389/fonc.2021.627023
dc.relation.volume	11